Yuji Nakada News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Yuji nakada. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Yuji Nakada Today - Breaking & Trending Today

Heart attack recovery aided by injecting heart muscle cells that overexpress cyclin D2


 E-Mail
IMAGE:  These results suggest that the cyclin D2-cardiomyocyte transplantation may be a potential therapeutic strategy for the repair of infarcted hearts, said study leader Jianyi Jay Zhang, M.D., Ph.D., the chair.
view more 
Credit: UAB
BIRMINGHAM, Ala. - In a large-animal study, researchers have shown that heart attack recovery is aided by injection of heart muscle cells derived from human induced pluripotent stem cell line, or hiPSCs, that overexpress cyclin D2. This research, published in the journal
Circulation, used a pig model of heart attacks, which more closely resembles the human heart in size and physiology, and thus has higher clinical relevance to human disease, compared to studies in mice. ....

United States , Vahid Serpooshan , Yuxin Chu , Gregoryp Walcott , Jianyi Jay Zhang , Yuhua Wei , Antonv Borovjagin , Meng Zhao , Yuji Nakada , Wuqiang Zhu , Thanh Nguyen , Division Of Cardiovascular Disease , School Of Medicine , Emory University , National Institutes Of Health , Department Of Biomedical Engineering , Georgia Institute Of Technology , Department Of Cardiovascular Diseases , University Of Alabama At Birmingham , School Of Engineering , Informatics Institute , Department Of Medicine , Biomedical Engineering , Weihua Bian , Min Xie , Cardiovascular Disease ,

Three longtime antibiotics could offer alternative to addictive opioid pain relievers


 E-Mail
IMAGE: This illustration shows the atomic level resolution of the tetracycline antibiotic bound to the EphB1 receptor.
view more 
Credit: UT Southwestern Medical Center
DALLAS - Feb. 22, 2021 - Three decades-old antibiotics administered together can block a type of pain triggered by nerve damage in an animal model, UT Southwestern researchers report. The finding, published online today in
PNAS, could offer an alternative to opioid-based painkillers, addictive prescription medications that are responsible for an epidemic of abuse in the U.S.
Over 100 million Americans are affected by chronic pain, and a quarter of these experience pain on a daily basis, a burden that costs an estimated $600 billion in lost wages and medical expenses each year. For many of these patients - those with cancer, diabetes, or trauma, for example - their pain is neuropathic, meaning it s caused by damage to pain-sensing nerves. ....

United States , United Kingdom , Mahmouds Ahmed , Muhammad Ismail , Mark Henkemeyer , Ngoc Uyen Nhi Nguyen , Ivan Menendez Montes , Robert Bachoo , Yuji Nakada , Heshama Sadek , J Fred Schoellkopf Jr , Study Of Drug Development , British University , Hamon Center , Tufts Center , Martha Brooks Professorship In Nerve Growth Research , Drug Administration , University Of Alabama At Birmingham , Ut Southwestern Medical Center , Drug Development , Ping Wang , Martha Brooks Professorship , Nerve Growth , Regenerative Science , Medicine Health , ஒன்றுபட்டது மாநிலங்களில் ,